BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 27267072)

  • 21. High-resolution two-dimensional liquid chromatography analysis of key linker drug intermediate used in antibody drug conjugates.
    Venkatramani CJ; Huang SR; Al-Sayah M; Patel I; Wigman L
    J Chromatogr A; 2017 Oct; 1521():63-72. PubMed ID: 28942996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and optimization of a system for comprehensive two-dimensional liquid chromatography with UV and mass spectrometric detection for the separation of complex samples by multi-step gradient elution.
    Eggink M; Romero W; Vreuls RJ; Lingeman H; Niessen WM; Irth H
    J Chromatogr A; 2008 Apr; 1188(2):216-26. PubMed ID: 18339395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.
    Reusch D; Haberger M; Falck D; Peter B; Maier B; Gassner J; Hook M; Wagner K; Bonnington L; Bulau P; Wuhrer M
    MAbs; 2015; 7(4):732-42. PubMed ID: 25996192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycan analysis for protein therapeutics.
    Yang X; Bartlett MG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1120():29-40. PubMed ID: 31063953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-throughput multiplex analysis of mAb aggregates and charge variants by automated two-dimensional size exclusion-cation exchange chromatography coupled to mass spectrometry.
    Lambiase G; Inman SE; Muroni M; Lindo V; Dickman MJ; James DC
    J Chromatogr A; 2022 May; 1670():462944. PubMed ID: 35344792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights from native mass spectrometry and ion mobility-mass spectrometry for antibody and antibody-based product characterization.
    Terral G; Beck A; Cianférani S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():79-90. PubMed ID: 27108304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-dimensional liquid chromatography coupled to mass spectrometry for impurity analysis of dye-conjugated oligonucleotides.
    Koshel B; Birdsall R; Chen W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1137():121906. PubMed ID: 31877427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Combination of Native LC-MS Approaches for the Comprehensive Characterization of the Antibody-Drug Conjugate Trastuzumab Deruxtecan.
    Deslignière E; Diemer H; Erb S; Coliat P; Pivot X; Detappe A; Hernandez-Alba O; Cianférani S
    Front Biosci (Landmark Ed); 2022 Oct; 27(10):290. PubMed ID: 36336868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple heart-cutting and comprehensive two-dimensional liquid chromatography hyphenated to mass spectrometry for the characterization of the antibody-drug conjugate ado-trastuzumab emtansine.
    Sandra K; Vanhoenacker G; Vandenheede I; Steenbeke M; Joseph M; Sandra P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():119-130. PubMed ID: 27160547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of host-cell proteins in biotherapeutic proteins by comprehensive online two-dimensional liquid chromatography/mass spectrometry.
    Doneanu CE; Xenopoulos A; Fadgen K; Murphy J; Skilton SJ; Prentice H; Stapels M; Chen W
    MAbs; 2012; 4(1):24-44. PubMed ID: 22327428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. I - Optimization of separation conditions.
    Sarrut M; Corgier A; Fekete S; Guillarme D; Lascoux D; Janin-Bussat MC; Beck A; Heinisch S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():103-111. PubMed ID: 27426266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The versatility of heart-cutting and comprehensive two-dimensional liquid chromatography in monoclonal antibody clone selection.
    Sandra K; Steenbeke M; Vandenheede I; Vanhoenacker G; Sandra P
    J Chromatogr A; 2017 Nov; 1523():283-292. PubMed ID: 28668371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutting-edge capillary electrophoresis characterization of monoclonal antibodies and related products.
    Gahoual R; Beck A; Leize-Wagner E; François YN
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():61-78. PubMed ID: 27265157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization and stability study of polysorbate 20 in therapeutic monoclonal antibody formulation by multidimensional ultrahigh-performance liquid chromatography-charged aerosol detection-mass spectrometry.
    Li Y; Hewitt D; Lentz YK; Ji JA; Zhang TY; Zhang K
    Anal Chem; 2014 May; 86(10):5150-7. PubMed ID: 24749737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protocols for the analytical characterization of therapeutic monoclonal antibodies. III - Denaturing chromatographic techniques hyphenated to mass spectrometry.
    D'Atri V; Goyon A; Bobaly B; Beck A; Fekete S; Guillarme D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Oct; 1096():95-106. PubMed ID: 30149300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On-line coupling of size exclusion chromatography with mixed-mode liquid chromatography for comprehensive profiling of biopharmaceutical drug product.
    He Y; Friese OV; Schlittler MR; Wang Q; Yang X; Bass LA; Jones MT
    J Chromatogr A; 2012 Nov; 1262():122-9. PubMed ID: 22999205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Affinity profiling of monoclonal antibody and antibody-drug-conjugate preparations by coupled liquid chromatography-surface plasmon resonance biosensing.
    Lakayan D; Haselberg R; Gahoual R; Somsen GW; Kool J
    Anal Bioanal Chem; 2018 Dec; 410(30):7837-7848. PubMed ID: 30328504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microcapillary liquid chromatography/tandem mass spectrometry using alkaline pH mobile phases and positive ion detection.
    Tomlinson AJ; Chicz RM
    Rapid Commun Mass Spectrom; 2003; 17(9):909-16. PubMed ID: 12717763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Middle-up characterization of monoclonal antibodies by online reduction liquid chromatography-mass spectrometry.
    Verscheure L; Oosterlynck M; Cerdobbel A; Sandra P; Lynen F; Sandra K
    J Chromatogr A; 2021 Jan; 1637():461808. PubMed ID: 33385741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.